Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jennifer Diamond

Concepts (351)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Triple Negative Breast Neoplasms
16
2024
216
6.090
 Why?
Breast Neoplasms
27
2026
2456
4.240
 Why?
Antineoplastic Agents
23
2023
2197
2.370
 Why?
Immunoconjugates
7
2023
137
2.350
 Why?
Antineoplastic Combined Chemotherapy Protocols
20
2025
1958
2.230
 Why?
Pyrimidines
9
2021
533
2.170
 Why?
Protein Kinase Inhibitors
11
2025
970
1.710
 Why?
Piperazines
5
2023
381
1.580
 Why?
Paclitaxel
6
2022
256
1.490
 Why?
Camptothecin
9
2023
140
1.470
 Why?
Neoplasms
15
2026
2884
1.470
 Why?
Pyrazoles
6
2021
510
1.240
 Why?
Ovarian Neoplasms
5
2025
586
1.230
 Why?
Quinoxalines
2
2020
65
1.220
 Why?
Azepines
3
2020
107
1.140
 Why?
Histone Deacetylase Inhibitors
4
2024
220
1.120
 Why?
Antibodies, Monoclonal, Humanized
10
2024
988
1.120
 Why?
Cyclin-Dependent Kinase 4
2
2018
53
1.010
 Why?
Cyclin-Dependent Kinase 6
2
2018
49
1.010
 Why?
Carcinoma, Lobular
3
2026
56
0.850
 Why?
Neutropenia
4
2022
155
0.820
 Why?
Benzoxazoles
2
2021
20
0.810
 Why?
Xenograft Model Antitumor Assays
12
2026
930
0.730
 Why?
Gene Expression Regulation, Neoplastic
5
2020
1462
0.720
 Why?
Maximum Tolerated Dose
10
2026
212
0.700
 Why?
Breast Neoplasms, Male
2
2018
29
0.690
 Why?
beta Catenin
2
2020
253
0.690
 Why?
Female
59
2026
78376
0.670
 Why?
Chemotherapy, Adjuvant
4
2023
421
0.640
 Why?
Cancer Care Facilities
1
2020
48
0.630
 Why?
Lymphocytes, Tumor-Infiltrating
2
2020
154
0.630
 Why?
Receptors, Estrogen
3
2021
457
0.630
 Why?
Tumor Microenvironment
5
2026
735
0.610
 Why?
Nuclear Proteins
3
2026
749
0.610
 Why?
eIF-2 Kinase
1
2019
29
0.610
 Why?
Humans
70
2026
144957
0.580
 Why?
Anthracyclines
3
2023
47
0.570
 Why?
Pyridines
5
2025
605
0.560
 Why?
Taxoids
3
2023
116
0.560
 Why?
Aged
27
2026
25947
0.540
 Why?
Carcinoma, Ductal, Breast
1
2018
88
0.530
 Why?
Aurora Kinase A
4
2020
62
0.530
 Why?
Wnt Signaling Pathway
1
2019
210
0.520
 Why?
Drug Resistance, Neoplasm
4
2020
883
0.510
 Why?
Trastuzumab
4
2023
118
0.510
 Why?
Pyrazines
2
2018
93
0.500
 Why?
Aromatase Inhibitors
3
2025
75
0.490
 Why?
Colonic Neoplasms
1
2018
260
0.480
 Why?
Myocardial Infarction
1
2023
1209
0.470
 Why?
Tumor Suppressor Protein p53
4
2024
531
0.460
 Why?
Cell Line, Tumor
11
2026
3550
0.460
 Why?
Angiopoietin-1
1
2015
12
0.450
 Why?
Angiopoietin-2
1
2015
15
0.450
 Why?
Neoplasm Recurrence, Local
5
2025
1141
0.440
 Why?
Neoadjuvant Therapy
1
2018
463
0.440
 Why?
Middle Aged
28
2026
35928
0.410
 Why?
Medicare
4
2023
887
0.400
 Why?
Uterine Cervical Neoplasms
1
2017
269
0.400
 Why?
Bridged-Ring Compounds
2
2023
31
0.400
 Why?
Adult
29
2026
40506
0.390
 Why?
Colorectal Neoplasms
5
2022
848
0.380
 Why?
Dose-Response Relationship, Drug
6
2022
2032
0.380
 Why?
Tumor Suppressor Proteins
1
2015
321
0.370
 Why?
Proto-Oncogene Proteins c-met
1
2013
76
0.370
 Why?
Cell Proliferation
8
2020
2499
0.370
 Why?
Lung Neoplasms
3
2026
2642
0.370
 Why?
Quinolines
4
2025
193
0.370
 Why?
Antibodies, Monoclonal
4
2024
1524
0.370
 Why?
Recombinant Fusion Proteins
1
2015
675
0.360
 Why?
Antineoplastic Agents, Immunological
3
2019
199
0.360
 Why?
Treatment Outcome
13
2025
11695
0.360
 Why?
Radiosurgery
3
2025
401
0.360
 Why?
Point Mutation
1
2013
243
0.360
 Why?
Neoplasm Metastasis
5
2026
695
0.360
 Why?
Triazoles
1
2013
184
0.350
 Why?
Angiogenesis Inhibitors
3
2018
237
0.340
 Why?
Mice, Nude
6
2020
688
0.330
 Why?
Aged, 80 and over
10
2025
8279
0.320
 Why?
Clinical Trials, Phase I as Topic
2
2020
52
0.320
 Why?
Carcinoma, Renal Cell
1
2013
234
0.320
 Why?
Mitochondria
1
2017
984
0.310
 Why?
Heart Failure
1
2023
2323
0.310
 Why?
Histones
3
2023
670
0.310
 Why?
Genes, BRCA2
1
2009
33
0.310
 Why?
Adaptor Proteins, Signal Transducing
2
2026
428
0.310
 Why?
Genes, BRCA1
1
2009
45
0.300
 Why?
Molecular Targeted Therapy
3
2019
434
0.290
 Why?
Biomarkers, Tumor
2
2014
1322
0.290
 Why?
BRCA2 Protein
1
2009
67
0.290
 Why?
Apoptosis
7
2024
2430
0.290
 Why?
Pregnancy Complications, Neoplastic
1
2009
63
0.290
 Why?
Thrombophilia
1
2009
88
0.290
 Why?
Neoplasm Staging
5
2021
1465
0.280
 Why?
Kidney Neoplasms
1
2013
412
0.280
 Why?
Mice
12
2026
18365
0.280
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2026
132
0.280
 Why?
Adenine
2
2021
339
0.270
 Why?
Receptors, Progesterone
2
2021
356
0.260
 Why?
DNA-Binding Proteins
1
2015
1500
0.260
 Why?
Aminopyridines
3
2026
127
0.250
 Why?
Nicotinamide Phosphoribosyltransferase
1
2026
8
0.240
 Why?
Models, Biological
1
2014
1822
0.240
 Why?
Cell Cycle Proteins
3
2026
629
0.230
 Why?
Selective Estrogen Receptor Modulators
1
2025
36
0.230
 Why?
Doxorubicin
3
2024
397
0.220
 Why?
Cardiorespiratory Fitness
1
2025
72
0.220
 Why?
Animals
15
2026
38109
0.210
 Why?
Biopsy
3
2018
1077
0.210
 Why?
Cyclophosphamide
2
2018
266
0.200
 Why?
DNA Repair
1
2026
256
0.200
 Why?
Trans-Activators
1
2026
405
0.200
 Why?
Wound Healing
1
2026
351
0.190
 Why?
Disease Models, Animal
3
2021
4569
0.190
 Why?
Brain Neoplasms
3
2025
1322
0.190
 Why?
United States
5
2023
15988
0.190
 Why?
Liver Neoplasms
1
2009
783
0.190
 Why?
Cyclin-Dependent Kinase 9
1
2022
18
0.180
 Why?
Histone Deacetylase 1
1
2022
23
0.180
 Why?
Aurora Kinases
2
2012
28
0.180
 Why?
G2 Phase Cell Cycle Checkpoints
3
2022
44
0.180
 Why?
Topoisomerase I Inhibitors
2
2022
19
0.180
 Why?
Administration, Oral
3
2022
848
0.170
 Why?
Fluorouracil
1
2022
235
0.170
 Why?
Disease Progression
4
2019
2852
0.170
 Why?
Acetylation
1
2022
256
0.170
 Why?
Androstadienes
1
2021
76
0.170
 Why?
Biliary Tract Neoplasms
1
2021
31
0.160
 Why?
Arrhythmias, Cardiac
1
2023
361
0.160
 Why?
Carboplatin
1
2021
160
0.160
 Why?
Heterografts
1
2021
144
0.160
 Why?
Drug Administration Schedule
3
2017
783
0.160
 Why?
Diarrhea
2
2019
192
0.160
 Why?
Hospitals, University
1
2021
176
0.160
 Why?
Necrosis
2
2019
244
0.160
 Why?
Male
16
2026
72406
0.160
 Why?
Histone Deacetylases
1
2022
210
0.160
 Why?
Cancer Survivors
1
2025
327
0.160
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
63
0.160
 Why?
Fatigue
2
2022
366
0.160
 Why?
Immunotherapy
2
2023
657
0.150
 Why?
Immune System
1
2021
179
0.150
 Why?
Clinical Trials as Topic
3
2016
1054
0.150
 Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2019
39
0.150
 Why?
Benzodiazepines
1
2021
168
0.150
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
139
0.150
 Why?
Corneal Ulcer
1
1999
20
0.150
 Why?
Kaplan-Meier Estimate
1
2021
966
0.150
 Why?
Tumor Cells, Cultured
1
2020
919
0.140
 Why?
Albumins
1
2019
118
0.140
 Why?
Aquaporin 4
1
2019
98
0.140
 Why?
Maintenance Chemotherapy
1
2018
42
0.140
 Why?
Sucrase
1
1998
2
0.140
 Why?
Vascular Endothelial Growth Factor A
2
2018
557
0.140
 Why?
Microvilli
1
1998
75
0.140
 Why?
Cornea
1
1999
155
0.140
 Why?
Cytokines
1
2026
2065
0.140
 Why?
Nausea
1
2018
111
0.140
 Why?
Mice, Inbred BALB C
1
2020
1253
0.130
 Why?
Drug Therapy, Combination
1
2020
1048
0.130
 Why?
Breast
1
2018
159
0.130
 Why?
Antibodies, Bispecific
1
2018
64
0.130
 Why?
Radiotherapy, Adjuvant
1
2018
222
0.130
 Why?
Purines
1
2018
187
0.130
 Why?
Topotecan
1
2017
17
0.130
 Why?
Benzimidazoles
1
2018
190
0.130
 Why?
Isoflavones
1
2017
26
0.130
 Why?
Bacterial Infections
1
1999
246
0.130
 Why?
Calcium-Binding Proteins
1
2018
220
0.130
 Why?
Mastectomy
1
2018
162
0.130
 Why?
Imidazoles
1
2018
254
0.130
 Why?
Heterocyclic Compounds, 4 or More Rings
1
2017
23
0.130
 Why?
Carbolines
1
2017
35
0.130
 Why?
Survival Analysis
1
2020
1385
0.130
 Why?
Inhibitory Concentration 50
2
2016
91
0.120
 Why?
Programmed Cell Death 1 Receptor
1
2019
264
0.120
 Why?
Hypertension
2
2018
1264
0.120
 Why?
Cell Survival
1
2019
1098
0.120
 Why?
Neoplasms, Radiation-Induced
1
2016
99
0.120
 Why?
Insulin-Like Growth Factor I
1
2018
319
0.120
 Why?
Retrospective Studies
4
2025
17101
0.120
 Why?
GPI-Linked Proteins
1
2016
81
0.120
 Why?
Neoplasms, Second Primary
1
2016
100
0.110
 Why?
Tumor Protein p73
1
2015
18
0.110
 Why?
Antibodies, Neoplasm
1
2015
35
0.110
 Why?
Phosphorylation
1
2019
1733
0.110
 Why?
Carcinoma, Non-Small-Cell Lung
1
2024
1182
0.110
 Why?
Risk Reduction Behavior
1
2016
226
0.110
 Why?
Hodgkin Disease
1
2016
171
0.110
 Why?
Nanoparticles
1
2021
520
0.110
 Why?
Oxazoles
2
2025
48
0.110
 Why?
Maytansine
1
2014
18
0.110
 Why?
Demography
1
2015
288
0.100
 Why?
Brain Edema
1
2014
62
0.100
 Why?
Protein Kinases
1
2015
315
0.100
 Why?
Drug Interactions
1
2015
401
0.100
 Why?
Survival Rate
2
2019
2092
0.100
 Why?
Exercise
1
2025
2201
0.100
 Why?
Threonine
1
2013
46
0.100
 Why?
Sulfones
1
2014
127
0.100
 Why?
Tumor Stem Cell Assay
1
2012
34
0.100
 Why?
Quinazolines
2
2025
266
0.100
 Why?
Drug Evaluation, Preclinical
1
2013
194
0.090
 Why?
Randomized Controlled Trials as Topic
1
2019
1721
0.090
 Why?
Glycine
1
2014
187
0.090
 Why?
Diabetes Mellitus, Type 2
2
2025
2584
0.090
 Why?
Bacteria
1
1999
889
0.090
 Why?
Drug Design
1
2013
173
0.090
 Why?
Methionine
1
2013
162
0.090
 Why?
Time Factors
2
2020
7183
0.090
 Why?
Heterozygote
1
2013
315
0.090
 Why?
In Situ Hybridization, Fluorescence
1
2013
323
0.090
 Why?
Intestinal Mucosa
1
1998
676
0.090
 Why?
Treatment Failure
1
2013
365
0.090
 Why?
Disease-Free Survival
1
2014
769
0.090
 Why?
Analgesics, Opioid
1
2021
1143
0.090
 Why?
Neovascularization, Pathologic
1
2013
286
0.090
 Why?
Cell Transformation, Neoplastic
1
2013
339
0.080
 Why?
Receptor Protein-Tyrosine Kinases
1
2013
230
0.080
 Why?
Cluster Analysis
1
2012
521
0.080
 Why?
Carcinoma in Situ
1
2011
44
0.080
 Why?
Risk Assessment
1
2020
3676
0.080
 Why?
Computational Biology
1
2015
681
0.080
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2010
85
0.080
 Why?
Risk Factors
2
2025
10792
0.080
 Why?
Colorado
1
2020
4564
0.080
 Why?
Cellular Senescence
1
2012
226
0.080
 Why?
Sequence Analysis, DNA
1
2013
824
0.080
 Why?
Mutation
2
2012
4099
0.080
 Why?
Tumor Burden
1
2010
322
0.070
 Why?
Gastric Emptying
1
2009
36
0.070
 Why?
Keratinocytes
1
2010
250
0.070
 Why?
Pregnancy Trimester, Second
1
2009
82
0.070
 Why?
Enteric Nervous System
1
2009
25
0.070
 Why?
Stomach
1
2009
109
0.070
 Why?
Mastectomy, Segmental
1
2009
108
0.070
 Why?
Pregnancy Trimester, First
1
2009
136
0.070
 Why?
Apoptosis Regulatory Proteins
1
2009
187
0.070
 Why?
Muscle, Smooth
1
2009
153
0.070
 Why?
Lymph Node Excision
1
2009
173
0.070
 Why?
Diabetes Mellitus, Experimental
1
2009
198
0.070
 Why?
Risk
1
2009
911
0.060
 Why?
Cell Adhesion Molecules
2
2019
178
0.060
 Why?
Infusions, Intravenous
2
2019
423
0.060
 Why?
Pentosyltransferases
1
2026
6
0.060
 Why?
Cyclic Nucleotide Phosphodiesterases, Type 4
1
2026
15
0.060
 Why?
Antigens, Neoplasm
2
2019
272
0.060
 Why?
Phosphodiesterase 4 Inhibitors
1
2026
12
0.060
 Why?
Prognosis
2
2018
4293
0.060
 Why?
Cyclopropanes
1
2026
83
0.060
 Why?
Acrylamides
1
2026
70
0.060
 Why?
Gene Expression Profiling
1
2012
1786
0.060
 Why?
Phthalazines
1
2026
64
0.060
 Why?
Cyclic AMP Response Element-Binding Protein
1
2026
145
0.060
 Why?
CD8-Positive T-Lymphocytes
2
2023
917
0.060
 Why?
Alveolar Epithelial Cells
1
2026
120
0.050
 Why?
Benzamides
1
2026
224
0.050
 Why?
Accelerometry
1
2025
119
0.050
 Why?
Cell Cycle
2
2018
597
0.050
 Why?
Combined Modality Therapy
2
2019
1268
0.050
 Why?
Mesylates
1
2022
7
0.050
 Why?
Follow-Up Studies
2
2025
5417
0.050
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
69
0.050
 Why?
Signal Transduction
2
2014
5233
0.050
 Why?
Oxygen Consumption
1
2025
724
0.050
 Why?
Clinical Protocols
1
2023
282
0.040
 Why?
Ligands
1
2024
674
0.040
 Why?
RNA, Small Interfering
1
2024
635
0.040
 Why?
Chimerism
1
2021
35
0.040
 Why?
Lymphocyte Subsets
1
2021
83
0.040
 Why?
Lymphoid Tissue
1
2021
80
0.040
 Why?
Blood Glucose
3
2025
2330
0.040
 Why?
Liver
1
2009
1888
0.040
 Why?
Mice, SCID
1
2021
369
0.040
 Why?
Hormones
1
2020
134
0.040
 Why?
SEER Program
1
2021
224
0.040
 Why?
Mice, Inbred NOD
1
2021
610
0.040
 Why?
Bacteriological Techniques
1
1999
68
0.040
 Why?
Immunohistochemistry
2
2016
1718
0.040
 Why?
M Phase Cell Cycle Checkpoints
1
2018
24
0.040
 Why?
Monosaccharide Transport Proteins
1
1998
56
0.030
 Why?
Tissue Distribution
1
2018
334
0.030
 Why?
Infant, Newborn
1
2009
6434
0.030
 Why?
Anemia
1
2019
188
0.030
 Why?
Insulin Resistance
1
2025
1241
0.030
 Why?
Intestine, Small
1
1998
166
0.030
 Why?
Biological Transport
1
1998
418
0.030
 Why?
Pregnancy
1
2009
7191
0.030
 Why?
In Vitro Techniques
1
1998
1048
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
112
0.030
 Why?
Cetuximab
1
2016
111
0.030
 Why?
Retreatment
1
2016
77
0.030
 Why?
Neoplasm Transplantation
1
2016
252
0.030
 Why?
Drug Screening Assays, Antitumor
1
2016
191
0.030
 Why?
Platinum
1
2016
50
0.030
 Why?
Carotid Artery Diseases
1
1996
69
0.030
 Why?
Arterial Occlusive Diseases
1
1996
90
0.030
 Why?
Proto-Oncogene Proteins p21(ras)
1
2016
253
0.030
 Why?
History, Ancient
1
2015
56
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
676
0.030
 Why?
Transcription Factors
1
2023
1742
0.030
 Why?
C-Peptide
1
1996
189
0.030
 Why?
Carotid Arteries
1
1996
207
0.030
 Why?
Femoral Artery
1
1996
190
0.030
 Why?
Databases, Genetic
1
2015
249
0.030
 Why?
Kinetics
1
1998
1629
0.030
 Why?
Diabetic Angiopathies
1
1996
263
0.030
 Why?
Biomarkers
2
2016
4275
0.030
 Why?
DNA Damage
1
2017
430
0.030
 Why?
Mice, Knockout
1
2021
3125
0.030
 Why?
Cross-Sectional Studies
1
2025
5872
0.030
 Why?
Quality of Life
1
2025
3192
0.020
 Why?
Phenotype
1
2021
3164
0.020
 Why?
Glucose
1
1998
1049
0.020
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
257
0.020
 Why?
Tomography, X-Ray Computed
2
2016
2738
0.020
 Why?
Opioid-Related Disorders
1
2021
601
0.020
 Why?
Drug Combinations
1
2013
392
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2015
460
0.020
 Why?
Lipids
1
1996
710
0.020
 Why?
Biopsy, Needle
1
2011
183
0.020
 Why?
Proto-Oncogene Proteins
1
2014
623
0.020
 Why?
HT29 Cells
1
2010
37
0.020
 Why?
Enzyme Inhibitors
1
2014
826
0.020
 Why?
Protein-Tyrosine Kinases
1
2013
433
0.020
 Why?
Cohort Studies
1
2021
5965
0.020
 Why?
Transcription, Genetic
1
2017
1496
0.020
 Why?
ErbB Receptors
1
2013
629
0.020
 Why?
Ki-67 Antigen
1
2010
117
0.020
 Why?
Capillary Permeability
1
2010
134
0.020
 Why?
Gastrointestinal Motility
1
2009
29
0.020
 Why?
Patient Selection
1
2013
719
0.020
 Why?
Biological Clocks
1
2009
49
0.020
 Why?
Patient Satisfaction
1
2013
705
0.020
 Why?
Tomography, Emission-Computed, Single-Photon
1
2009
104
0.020
 Why?
Microscopy, Electron
1
2009
415
0.020
 Why?
Membrane Proteins
1
2015
1167
0.020
 Why?
Positron-Emission Tomography
1
2010
343
0.020
 Why?
Rats, Wistar
1
2009
451
0.020
 Why?
Algorithms
1
2015
1839
0.020
 Why?
Magnetic Resonance Imaging
1
2019
3869
0.020
 Why?
Insulin
1
1996
2507
0.010
 Why?
Adolescent
1
2024
22453
0.010
 Why?
Brain
1
2014
2941
0.010
 Why?
Rats
1
2009
5614
0.010
 Why?
Young Adult
1
2014
14126
0.010
 Why?
Tunica Media
1
1996
37
0.010
 Why?
Cholesterol, HDL
1
1996
200
0.010
 Why?
Fasting
1
1996
277
0.010
 Why?
Cholesterol
1
1996
408
0.010
 Why?
Regression Analysis
1
1996
1003
0.010
 Why?
Ultrasonography
1
1996
770
0.010
 Why?
Diamond's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (351) concept(s)
_
Co-Authors Expand Description
See all (75) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)